Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,23
KB-0,46
PKN67,6867,70,89
Msft400,53400,6-0,92
Nokia3,3183,34953,52
IBM181,76181,810,14
Mercedes-Benz Group AG74,0874,1-0,90
PFE25,8225,831,69
19.04.2024 20:06:46
Indexy online
AD Index online
select
AD Index online
 

  • 19.04.2024 10:20:01
Olympus (OOPT.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
12,90 -5,87 -0,81 15 480
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.04.2024
Popis společnosti
Obecné informace
Název společnostiOlympus Corp
Ticker7733
Kmenové akcie:Ordinary Shares
RIC7733.T
ISINJP3201200007
Poslední známé roční výsledky31.03.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.03.2023 32 844
Akcie v oběhu k 31.12.20231 183 443 085
MěnaJPY
Kontaktní informace
UliceShinjuku Monolith, 2-3-1, Nishi-Shinjuku
MěstoSHINJUKU-KU
PSČ163-0914
ZeměJapan
Kontatní osobaTakaaki Sakurai
Funkce kontaktní osobyVice President of IR Division
Telefon81 333 402 111
Fax81333402062
Kontatní telefon81 333 402 111

Business Summary: Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Financial Summary: BRIEF: For the nine months ended 31 December 2023, Olympus Corp revenues increased 5% to Y675.71B. Net income before extraordinary items decreased 93% to Y7.13B. Revenues reflect Endoscope segment increase of 4% to Y376.93B, Therapeutic Devices segment increase of 6% to Y247.23B, Equipment Sector segment increase of 12% to Y42.39B, Northern America (Region) segment increase of 4% to Y249.16B, Europe segment increase of 6% to Y170.89B.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSCommercial and Service Industry Machinery Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSInstruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
NAICSIrradiation Apparatus Manufacturing
NAICSMiscellaneous Financial Investment Activities
NAICS2007Electromedical Apparatus Mfg
NAICS2007Optical Instrument & Lens Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Industrial Process Control Mfg
NAICS2007Photographic & Photocopying Equipment Mfg
NAICS2007Custom Computer Programming Services
NAICS2007Irradiation Apparatus Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Optical Instrument and Lens Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
NAICS1997Photographic and Photocopying Equipment Manufacturing
NAICS1997Custom Computer Programming Services
NAICS1997Irradiation Apparatus Manufacturing
SICElectromedical Equipment
SICService Industry MacHinery, Nec
SICSurgical And Medical Instruments
SICProcess Control Instruments
SICX-Ray Apparatus And Tubes
SICSecurity/commodity Services Nec



  • Poslední aktualizace: 19.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Executive Board, Representative Executive Officer, ESG Officer, DirectorYasuo Takeuchi6626.06.2009
Executive President, Chief Executive Officer, Representative Executive Officer, DirectorStefan Kaufmann55
Executive Officer, Chief Financial OfficerTatsuya Izumi-01.04.202401.04.2024
Executive Officer, Chief Human Resource OfficerShigeto Ohtsuki61
Executive Officer, Chief Technology OfficerAndre Roggan6001.04.2022
Executive Officer, Deputy Chief Technology Officer, President of SubsidiaryTomohisa Sakurai-
Executive Officer, Chief Information OfficerStephen Kneebone-
Executive Officer, President of SubsidiaryKoji Ando-
Executive Officer, Chairman of SubsidiaryFrank Drewalowski58
Executive OfficerKazutaka Eguchi-